Pharmaceuticals, Biotechnology and Life Sciences
CAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) — Checkmate Pharmaceuticals, Inc. (Nasdaq: CMPI) (“Checkmate”), a clinical stage biopharmaceutical company focused…
Positive top-line results from registration-enabling study of cosibelimab in metastatic cutaneous squamous cell carcinoma announced in January 2022; BLA submission…
Company on track to dose first transfusion-dependent beta thalassemia patient with EDIT-301 by year-endCAMBRIDGE, Mass., May 12, 2022 (GLOBE NEWSWIRE) —…
AUSTIN, Texas, May 12, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or “MTEM”), a clinical-stage biopharmaceutical company…
– Peer-reviewed publication highlights 22 new oncogenic HER2 driver mutations identified and experimentally validated with MAP discovery engine – CAMBRIDGE,…
Montrouge, France, May 12, 2022 DBV Technologies Announces Results of Its 2022 Ordinary and Extraordinary General Meeting Shareholders Approved All…
BLEScath™ Intratracheal catheter for less invasive administration of pulmonary surfactant NRDS is a challenge mitigated by integrated scientific solutions. LONDON,…
– Dr. O’Donnell-Tormey is a cancer immunology key opinion leader with more than 30 years leading the Cancer Research Institute’s…
CHARLOTTESVILLE, Va. and CARMEL, Ind., May 11, 2022 (GLOBE NEWSWIRE) — Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical stage biopharmaceutical…
New facility will also serve as regional headquarters for Singleron in Asia Proteona opens new laboratory in Singapore New laboratory…